The Not-So-Simple Process of Sickle Cell Vasoocclusion

REFERENCES

• Abboud M, Laver J, Blau C A. 1998. Granulocytosis causing sickle-cell crisis. Lancet. 351: 959, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Akinola N O, Stevens S ME, Franklin I M, Nash G B, Stuart J. 1992. Subclinical ischaemic episodes during the steady state of sickle cell anemia. J Clin Pathol. 45: 902–906. [PUBMED], [INFOTRIEVE]
   Google Scholar
• Akinola N O, Stevens S ME, Franklin I M, Nash G B, Stuart J. 1992. Rheological changes in the prodromal and established phases of sickle cell vasoocclusive crisis. Br J Haematol. 81: 598–602. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Aslan M, Ryan T M, Adler B, Townes T M, Parks D A, Thompson J A, Tousson A, Gladwin M T, Patel R P, Tarpey M M, Batinic-Haberle I, White C R, Freeman B A. 2001. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc Natl Acad Sci USA. 98: 15215–15220. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ballas S K. 1998; Sickle Cell Pain: Progress in Pain Research and Management. Vol. 11, Seattle, IASP Press. 1–379
   Google Scholar
• Ballas S K, Larner J, Smith E D, Surrey S, Schwartz E, Rappaport E F. 1988. Rheologic predictors of the severity of the painful sickle cell crisis. Blood. 72: 1216–1223. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ballas S K, Smith E D. 1992. Red blood cell changes during the evolution of the sickle cell painful crisis. Blood. 79: 2154–2163. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Bassingthwaighte J B, Van, Beek J H, King R B. 1993. Fractal branchings: the basis of myocardial flow heterogeneities?. Ann NY Acad Sci. 591: 392–401
   Google Scholar
• Bookchin R M, Balazs T, Landau L C. 1976. Determinants of red cell sickling: effects of varying pH and of increasing intracellular hemoglobin concentration by osmotic shrinkage. J Lab Clin Med. 87: 597–616. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Bookchin R M, Nagel R L. 1974. Interactions between human hemoglobins: sickling and related phenomena. Semin Hematol. 11: 577–595. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Bourantas K L, Dalekos G N, Makis A, Chaidos A, Tsiara S, Mavridis A. 1998. Acute phase proteins and interleukins in steady state sickle cell disease. Eur J Haematol. 61: 49–54. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Brittenham G M, Schechter A N, Noguchi C T. 1985. Hemoglobin S polymerization: primary determination of the hemolytic and clinical severity of the sickling syndromes. Blood. 65: 283–289
   Google Scholar
• Brooks L J, Koziol S M, Chiarucci K M, Berman B W. 1996. Does sleep-disordered breathing contribute to the clinical severity of sickle cell anemia?. J Pediatr Hematol Oncol. 18: 135–139. [CROSSREF], [PUBMED], [INFOTRIEVE]
   Google Scholar
• Brugnara C. 1994. Cation Homeostasis. Sickle Cell Disease: Basic Principles and Clinical Practice, S H, Embury, R P, Hebbel, N, Mohandas, M H, Steinberg, New York, Raven. 173–194
   Google Scholar
• Bunn H F, Noguchi C T, Hofrichter J, Schechter G P, Schechter A N, Eaton W A. 1982. Molecular and cellular pathogenesis of Hb SC disease. Proc Natl Acad Sci USA. 79: 7527–7531. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Charache S, Barton F B, Moore R D, Terrin M L, Steinberg M H, Dover G J, Ballas S K, McMahon R P, Castro O, Orringer E P. 1996. Hydroxyurea and sickle cell anemia: clinical utility of a myelosuppressive “switching” agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Medicine. 75: 300–326. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Charache S, de la, Monte S, MacDonald V. 1982. Increased blood viscosity in a patient with sickle cell anemia. Blood Cells. 8: 103–109. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Charache S, Dover G J, Moore R D, Eckert S, Ballas S K, Koshy M, Milner P FA, Orringer E P, Phillips G, Jr., Platt O S, Thomas G H. 1992. Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia. Blood. 79: 2555–2565. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Chien S, Usami S, Skalak R. 1993. Blood flow in small tubes. Handbook of Physiology, E M, Renkin, C C, Michel, S R, Geiger, Bethesda, MD, American Physiological Society. 217–249
   Google Scholar
• Clark M R, Mohandas N, Shohet S B. 1980. Deformability of oxygenated irreversibly sickled cells. J Clin Invest. 65: 189–196. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Closse C, Seigneur M, Renard M, Pruvost A, Dumain P, Belloc F, Boisseau M R. 1997. Influence of hypoxia and hypoxia-reoxygenation on endothelial P-selectin expression. Thromb Res. 85: 159–164. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Coburn R F, Williams W J, Kahn S B. 1966. Endogenous carbon monoxide production in patients with hemolytic anemia. J Clin Invest. 45: 460–468. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Conley C L, Weatherall D J, Richardson S N, Shepard M K, Charache S. 1963. Hereditary persistence of fetal hemoglobin: a study of 79 affected persons in 15 negro families in Baltimore. Blood. 21: 261–281. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Eaton W A, Hofrichter J. 1990. Sickle cell hemoglobin polymerization. Adv Prot Chem. 40: 63–279
   PubMedGoogle Scholar
• Embury S H, Clark M R, Monroy G M, Mohandas N. 1984. Concurrent sickle cell anemia and α thalassemia: effect on pathological properties of sickle red cells. J Clin Invest. 73: 116–123. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Embury S H, Garcia J F, Mohandas N, Pennathur-Das R, Clark M R. 1984. Effects of oxygen inhalation on endogenous erythropoietin kinetics, erythropoiesis, and properties of blood cells in sickle-cell anemia. N Engl J Med. 311: 291–295. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Embury S H, Hebbel R P, Mohandas N, Steinberg M H. 1994. Pathogenesis of Vasoocclusion. Sickle Cell Disease: Basic Principles and Clinical Practice, S H, Embury, R P, Hebbel, N, Mohandas, M H, Steinberg, New York, Raven. 311–326
   Google Scholar
• Embury S H, Matsui N M. 2002. Thrombin, endothelial gap formation, and eryhrocyte Adhesion. Interactions of Blood and the Pulmonary Circulation, E K, Weir, H L, Reeve, J T, Reeves, Armonk, NY, Futura. 35–68
   Google Scholar
• Embury S H, Matsui N M, Ranaujam S, Duong P L, Hebert J L, Khaimskiy Y, Parra M, Mohandas N, Cheung A TW. 2002. Thrombin receptor agonist peptide-1 and heparin modulation in vivo of mouse sickle erythrocyte flow dynamics in normal and P-selectin knockout mice, 30th Anniversary Combined Meeting of the National Sickle Cell Disease Program and the Sickle Cell Disease Association of America, (Abstr).
   Google Scholar
• Embury S H, Mohandas N, Paszty C, Cooper P, Cheung A TW. 1999. In vivo blood flow abnormalities in the transgenic knockout sickle cell mouse. J Clin Invest. 103: 915–920. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Embury S H, Vichinsky E P. 2000. Sickle cell disease. Hematology: Basic Principles and Practice, R R, Hoffman, E J, Benz, Jr., S J, Shattil, B, Furie, H J, Cohen, L E, Silberstein, P, McGlave, New York, Churchill Livingstone. 511–554
   Google Scholar
• Fabry M E, Benjamin L, Lawrence C, Nagel R L. 1984. An objective sign in painful crisis in sickle cell anemia: the concomitant reduction of high density red cells. Blood. 64: 559–563. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Fabry M E, Kaul D K, Raventos-Saurez C, Chang H, Nagel R L. 1982. SC erythrocytes have an abnormally high intracellular hamoglobin concentration. J Clin Invest. 70: 1315–1319. [PUBMED], [INFOTRIEVE]
   Google Scholar
• Faller D V. 1999. Endothelial cell responses to hypoxic stress. Clin Exp Pharmacol Physiol. 26: 74–84. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ferrone F A, Cho M R, Bishop M F. 1985. Can a successful mechanism for HbS gelation predict sickle cell crisis?. Approaches to the Therapy of Sickle Cell Anemia, Y, Beuzard, S, Charache, F, Galacteros, Paris, Les Editions Inserm. 53–66
   Google Scholar
• Francis R B, Jr., Hebbel R P. 1994. Hemostasis. Sickle Cell Disease: Basic Principles and Clinical Practice, S H, Embury, R P, Hebbel, N, Mohandas, M H, Steinberg, New York, Raven. 299–310
   Google Scholar
• Gladwin M T, Lancaster J R, Freeman B A, Schechter A N. 2003. Nitric oxide's reactions with hemoglobin: a view through the SNO-storm. Nat Med. 9: 496–500. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Goldberg M A, Husson M V, Bunn H F. 1977. Participation of hemoglobins A and F in polymerization of sickle hemoglobin. J Biol Chem. 252: 3414–3421. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Graido-Gonzalez E, Doherty J C, Bergreen E W, Organ G, Telfer M, McMillen M A. 1998. Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vasoocclusive sickle crisis. Blood. 92: 2551–255. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Gupta A K, Kirchner K A, Nicholson R, Adams J G, III, Schechter A N, Noguchi C T, Steinberg M H. 1991. Effects of α-thalassemia and sickle polymerization tendency on the urine-concentrating defect of individuals with sickle cell trait. J Clin Invest. 88: 1963–1968. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hammerman S I, Kourembanas S, Conca T J, Tucci M, Brauer M, Farber H W. 1997. Endothelin-1 production during the acute chest syndrome in sickle cell disease. Am J Resp Cell Mol Biol. 156: 280–285
   Google Scholar
• Harlan J M. 2000. Introduction: anti-adhesion therapy in sickle cell disease. Blood. 95: 365–367. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hebbel R P. 1991. Beyond hemoglobin polymerization: the red blood cell membrane sickle cell disease pathophysiology. Blood. 77: 214–237. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hebbel R P. 1997. Adhesive interactions of sickle erythrocytes with endothelium. J Clin Invest. 99: 2561–2564. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hebbel R P. 2000. Clinical implications of basic research: blockade of adhesion of sickle cells to endothelium by monoclonal antibodies. N Engl J Med. 342: 1910–1912. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hebbel R P, Boogaerts M AB, Eaton J W, Steinberg M H. 1980. Erythrocyte adherence to endothelium in sickle-cell anemia. N Engl J Med. 302: 992–995. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hebbel R P, Mohandas N. 1994. Sickle cell adherence. Sickle Cell Disease: Basic Principles and Clinical Practice, S H, Embury, R P, Hebbel, N, Mohandas, M H, Steinberg, New York, Raven. 217–230
   Google Scholar
• Hebbel R P, Visser M R, Goodman J L, Jacob H S, Vercellotti G M. 1987. Potentiated adherence of sickle erythrocytes to endothelium infected by virus. J Clin Invest. 80: 1503–1506. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hines P C, Zen Q, Burney S N, Shea D, Ataga K I, Orringer E P, Telen M J, Parise L V. 2003. Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesion. Blood. 101: 3281–3287. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Jung U, Ley K. 1999. Mice lacking two or all three selectins demonstrate overlapping and distinct functions for each selectin. J Immunol. 162: 6755–6762. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kaul D K, Fabry M E, Nagel R L. 1989. Erythrocytic and vascular factors influencing the microcirculatory behavior of blood in sickle cell anemia. Ann NY Acad Sci. 565: 316–326. [PUBMED], [INFOTRIEVE]
   Google Scholar
• Kaul D K, Fabry M E, Nagel R L. 1989. Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications. Proc Natl Acad Sci USA. 86: 3356–3360. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Lande W M, Andrews D L, Clark M R, Braham N V, Black D M, Embury S H. 1988. The incidence of painful crisis in homozygous sickle cell disease: correlation with red cell deformability. Blood. 72: 2056–2059. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Lefer D J, McLeod D S, Merges C, Lutty G A. 1993. Immunolocalization of ICAM-1 (CD 54) in the posterior eye of sickle cell and diabetic patients, Ophthal Vis Sci, (Abstr).
   Google Scholar
• Lipowsky H H, Sheikh N U, Katz D M. 1987. Intravital microscopy of capillary microdynamics in sickle cell disease. J Clin Invest. 80: 117–127. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Manodori A B. 2001. Sickle erythrocytes adhere to fibronectin–thrombospondin–integrin complexes exposed by thrombin-induced endothelial cell contraction. Microvasc Res. 61: 263–274. [CROSSREF], [PUBMED], [INFOTRIEVE]
   Google Scholar
• Manodori A B, Matsui N M, Chen J Y, Embury S H. 1998. Enhanced adherence of sickle erythrocytes to thrombin-treated endothelial cells involves interendothelial cell gap formation. Blood. 92: 3445–3454. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Masys D R, Bromberg P A, Balcerzak S P. 1974. Red cells shrink during sickling. Blood. 44: 885–889. [PUBMED], [INFOTRIEVE]
   Google Scholar
• Matsui N M, Borsig L, Rosen S D, Yaghmai M, Varki A, Embury S. 2001. P-selectin mediates the adhesion of sickle erythrocytes to the endothelium. Blood. 98: 1955–1962. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Matsui N M, Varki A, Embury S H. 2002. Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin. Blood. 100: 3790–3796. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Mondoro T H, Ryan B B, Hrinczenko B W, Schechter A N, Vostal J G, Alayash A I. 2001. Biological action of nitric oxide donor compounds on platelets from patients with sickle cell disease. Br J Haematol. 112: 1048–1054. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Morris C R, Kuypers F A, Larkin S, Vichinsky E P, Styles L A. 2000. Patterns of arginine and nitric oxide in patients with sickle cell disease with vasoocclusive crisis and acute chest syndrome. J Pediatr Hematol Oncol. 22: 515–520. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Morris C R, Morris S M, Hagar W, Van, Warmerdam J, Claster S, Kepka-Lenhart D, Machado L, Kuypers F A, Vichinsky E P. 2003. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?. Am J Respir Crit Care Med. 168: 63–69. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Nagel R L. 1993. Sickle cell anemia is a multigene disease: sickle painful crises, a case in point. Am J Hematol. 42: 96–101. [PUBMED], [INFOTRIEVE]
   Google Scholar
• Paszty C, Brion C M, Manci E, Witowska H E, Stevens M E, Mohandas N, Rubin E M. 1997. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science. 278: 876–878. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Perillie P E, Epstein F H. 1963. Sickling phenomenon produced by hypertonic solutions: a possible explanation for the hyposthenuria of sicklemia. J Clin Invest. 42: 570–580. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Phelan M, Perrine S P, Brauer M, Faller D V. 1995. Sickle erythrocytes, after sickling, regulate the expression of the endothelin-1 gene and protein in human endothelial cells in culture. J Clin Invest. 96: 1145–1151. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Platt O S, Brambilla D J, Rosse W F, Milner P F, Castro O, Steinberg M H, Klug P P. The Cooperative Study of Sickle Cell Disease, 1994. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med. 330: 1639–1644. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Reiter C D, Wang X, Tanus-Santos J E, Hogg N, Cannon R O, Schechter A N, Gladwin M T. 2002. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 8: 1383–1389. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Rodgers G P, Dover G J, Noguchi C T, Schechter A N, Nienhuis A W. 1990. Hematological responses of sickle cell patients treated with hydroxyurea. N Engl J Med. 322: 1037–1045. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Rodgers G P, Schechter A N, Noguchi C T, Klein H G, Nienhuis A W, Bonner R F. 1984. Periodic microcirculatory flow in patients with sickle-cell diesease. N Engl J Med. 311: 1534–1538. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sarelius I H, Duling B R. 1982. Direct measurement of microvessel hematocrit, red cell flux, velocity, and transit time. Am J Physiol. 243:H1018–H1026
   Google Scholar
• Schmalzer E, Chien S, Brown A K. 1982. Transfusion therapy in sickle cell disease. Am J Pediatr Hematol Oncol. 4: 395–406
   Google Scholar
• Schmalzer E A, Lee J O, Brown A K, Usami S, Chien S. 1987. Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels: implications for transfusion. Transfusion. 27: 228–233. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Schnog J J, Lard L R, Rojer R A, Van der, Dijs F P, Muskiet F A, Duits A J. 1998. New concepts in assessing sickle cell disease severity. Am J Hematol. 58: 61–66. [CROSSREF], [PUBMED], [INFOTRIEVE]
   Google Scholar
• Serjeant B E, Mason K P, Kenny K W, Stuart J, Higgs D R, Weatherall D J, Hayes R J, Serjeant G R. 1983. Effect of alpha thalassemia on the rheology of homozygous sickle cell disease. Br J Haematol. 55: 479–486. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Serjeant G R, Petch M C, Serjeant B E. 1973. The in vivo sickle phenomenon: a reappraisal. J Lab Clin Med. 81: 850–856. [PUBMED], [INFOTRIEVE]
   Google Scholar
• Setty B N, Chen D, O'Neal P, Littrell J B, Grossman M H, Stuart M J. 1998. Eicosanoids in sickle cell disease: potential relevance of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid to the pathophysiology of vasoocclusion. J Lab Clin Med. 131: 344–353. [CROSSREF], [PUBMED], [INFOTRIEVE]
   Google Scholar
• Sewchand L S, Johnson C S, Meiselman H J. 1983. The effect of fetal hemoglobin on the sickling dynamics of SS erythrocytes. Blood Cells. 9: 147–159. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Silverstein R L. 1999. The vascular endothelium. Inflammation: Basic Principles and Clinical Correlates, J I, Gallin, R, Snyderman, Philadelphia, Lippincott Williams & Wilkins. 207–225
   Google Scholar
• Singhal A, Doherty J F, Raynes J G, McAdam K PWJ, Thomas P W, Serjeant B E, Serjeant G R. 1993. Is there an acute-phase response in steady-state sickle cell disease?. Lancet. 341: 651–653. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Song J. 1971; Pathology of Sickle Cell Disease. Springfield, IL, Thomas
   Google Scholar
• Space S L, Lane P A, Pickett C K, Weil J V. 2000. Nitric oxide attenuates normal and sickle red blood cell adherence to pulmonary endothelium. Am J Hematol. 63: 200–204. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Stamler J S, Jia L, Eu J P, McMahon T J, Demchenko I T, Bonaventura J, Gernert K, Piantadosi C A. 1997. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science. 276: 2034–2037. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Steinberg M H, Embury S H. 1986. α-Thalassemia in blacks: genetic clinical aspects and interactions with the sickle hemoglobin gene. Blood. 68: 985–990. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Stockman J A, Nigro M A, Mishkin M M, Oski F A. 1972. Occlusion of large cerebral vessels in sickle cell anemia. N Engl J Med. 287: 846–849. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Stuart J, Stone P C, Akinola N O, Gallimore J R, Pepys M B. 1994. Monitoring the acute phase response to vasoocclusive crisis in sickle cell disease. J Clin Pathol. 47: 166–169. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sugihara K, Sugihara T, Mohandas N, Hebbel R P. 1992. Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells. Blood. 80: 2634–2642. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Swerlick R A, Eckman J R, Kumar A, Jetler M, Wick T M. 1993. α4b1-integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium. Blood. 82: 1891–1899. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Tomer A, Harker L A, Kasey S, Eckman J R. 2001. Thrombogenesis in sickle cell disease. J Lab Clin Med. 137: 398–407. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Treadwell M J, Gil K M. 1994. Psychosocial aspects. Sickle Cell Disease: Basic Principles and Clinical Practice, S H, Embury, R P, Hebbel, N, Mohandas, M H, Steinberg, New York, Raven. 517–529
   Google Scholar
• Turhan A, Weiss L A, Mohandas N, Coller B S, Frenette P S. 2002. Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Proc Natl Acad Sci USA. 99: 3047–3051. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Vichinsky E. 1994. Transfusion. Sickle Cell Disease: Basic Principles and Clinical Practice, S H, Embury, R P, Hebbel, N, Mohandas, M H, Steinberg, New York, Raven. 781–798
   Google Scholar
• Wang H U, Chen Z-F, Anderson D J. 1998. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell. 93: 741–753. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Werdehoff S G, Moore R B, Hoff C J, Fillingim E, Hackman A M. 1998. Elevated plasma endothelin-1 levels in sickle cell anemia: relationships to oxygen saturation and left ventricular hypertrophy. Am J Hematol. 58: 195–199. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Wood K, Russell J, Hebbel R P, Granger D N. 2004. Diffential expression of E- and P-selectin in the microvasculature of sickle cell transgenic mice. Microcirculation, (in press).
   Google Scholar
• Wun T. 2001. The role of inflammation and leukocytes in the pathogenesis of sickle cell disease. Hematol. 5: 403–412. [PUBMED], [INFOTRIEVE]
   Google Scholar
• Wun T, Paglieroni T, Tablin F, Welborn J, Nelson K, Cheung A. 1997. Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia. J Lab Clin Med. 129: 507–516. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Yang Y-M, Donnell C, Wilborn W, Goodman S R, Files B, Moore R B, Mohandas N, Mankad V N. 1992. Splenic sequestration associated with sickle cell trait and hereditary spherocytosis. Am J Hematol. 40: 110–116. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Yip K-P, Holstein-Rathlou N-H, March D J. 1991. Chaos in blood flow control in genetic and renovascular hypertensive rats. Am J Physiol. 261: F400–F408. [PUBMED], [INFOTRIEVE]
   Google Scholar